{
    "2019-10-15": [
        [
            {
                "time": "2018-10-15",
                "original_text": "Abbott Partnership Helps One Medtech Stock To Pop â€” As Another Dives",
                "features": {
                    "keywords": [
                        "partnership",
                        "medtech",
                        "stock pop",
                        "dives"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-16",
                "original_text": "DexCom Falls After Rival Tandem Teams With Abbott for Insulin Pump",
                "features": {
                    "keywords": [
                        "DexCom",
                        "Tandem",
                        "Abbott",
                        "insulin pump"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "diabetes care"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-10-17",
                "original_text": "Options Red-Hot Ahead of Abbott Earnings",
                "features": {
                    "keywords": [
                        "options",
                        "Abbott",
                        "earnings"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-18",
                "original_text": "Can Structural Heart Strength Aid Abbott (ABT) Q3 Earnings?",
                "features": {
                    "keywords": [
                        "structural heart",
                        "Q3 earnings",
                        "Abbott"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "cardiology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-19",
                "original_text": "Medical Devices Stock Rockets After Snagging An Abbott Partnership",
                "features": {
                    "keywords": [
                        "medical devices",
                        "Abbott",
                        "partnership"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-20",
                "original_text": "Abbott Labs Rises 3%",
                "features": {
                    "keywords": [
                        "Abbott Labs",
                        "rises"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-21",
                "original_text": "Abbott Forms Alliance With Omada Health for Diabetes Care",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Omada Health",
                        "diabetes care",
                        "alliance"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "diabetes care"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-22",
                "original_text": "Abbott Labs gets authorization for $3 billion in additional buybacks",
                "features": {
                    "keywords": [
                        "Abbott Labs",
                        "authorization",
                        "buybacks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-23",
                "original_text": "Abbott and Tandem Diabetes Care Exploring New Integrated Solutions to Improve Diabetes Management",
                "features": {
                    "keywords": [
                        "Abbott",
                        "Tandem Diabetes Care",
                        "integrated solutions",
                        "diabetes management"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "diabetes care"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Canadians Indicate Growing Concern About Road Safety at One-Year Anniversary of Recreational Cannabis Legalization, New Survey Finds",
                "features": {
                    "keywords": [
                        "road safety",
                        "cannabis legalization",
                        "survey"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "public policy",
                        "transportation"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "Abbott Laboratories Gets OK for Added $3 Billion of Stock Buybacks",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "OK",
                        "buybacks"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}